Cargando…
Adenosine A(2A) receptors in Parkinson’s disease treatment
Latest results on the action of adenosine A(2A) receptor antagonists indicate their potential therapeutic usefulness in the treatment of Parkinson’s disease. Basal ganglia possess high levels of adenosine A(2A) receptors, mainly on the external surfaces of neurons located at the indirect tracts betw...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583202/ https://www.ncbi.nlm.nih.gov/pubmed/18438720 http://dx.doi.org/10.1007/s11302-008-9100-8 |